[The problem of pharmacoresistant tremor in Parkinson's disease and essential tremor].

Autor:	Titova NV; Federal Center of Brain Research and Neurotechnologies, Moscow, Russia.; Pirogov Russian National Research Medical University, Moscow, Russia., Katunina EA; Federal Center of Brain Research and Neurotechnologies, Moscow, Russia.; Pirogov Russian National Research Medical University, Moscow, Russia., Tairova RT; Federal Center of Brain Research and Neurotechnologies, Moscow, Russia.; Pirogov Russian National Research Medical University, Moscow, Russia., Sen'ko IV; Federal Center of Brain Research and Neurotechnologies, Moscow, Russia., Dzhafarov VM; Federal Center of Brain Research and Neurotechnologies, Moscow, Russia., Malykhina EA; Federal Center of Brain Research and Neurotechnologies, Moscow, Russia.; Pirogov Russian National Research Medical University, Moscow, Russia.
Jazyk:	ruština
Zdroj:	Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2022; Vol. 122 (10), pp. 24-30.
DOI:	10.17116/jnevro202212210124
Abstrakt:	MR-guided focused ultrasound (MRg-FUS) is a new noninvasive method for the treatment of contralateral disabling and pharmacoresistant tremor. Clinical studies have confirmed the high efficacy and safety of using MRg-FUS in patients with essential tremor and Parkinson's disease, in short and long-term studies. Advantages of this method in comparison with currently used invasive and noninvasive technics, potential brain target areas, the possibility of bilateral intervention, indications and contraindications are discussed.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu